Brief: Heron Therapeutics Announces Q2 2025 Financial Results And Highlights Commercial Progress
08/08/2025 12:48
Aug 8 (Reuters) - Heron Therapeutics Inc HRTX.O: HERON THERAPEUTICS ANNOUNCES Q2 2025 FINANCIAL RESULTS AND HIGHLIGHTS COMMERCIAL PROGRESS Source text: ID:nPn3lDp5Ta Further company coverage: HRTX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Heron Therapeutics
See all newsHeron Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Heron Therapeutics Q2 revenue rises on acute care growth, withdraws 2026 outlook
Heron Therapeutics Inc expected to post earnings of 1 cent a share - Earnings Preview
Brief: U.S. District Court Issues Decision Regarding CINVANTI Patents
Heron Therapeutics' Q1 revenue falls as oncology sales drop